Associated Papers
Genetic landscape of phospholamban cardiomyopathies.
Vafiadaki E et al.
Frontiers in Cell and Developmental Biology, 2025
Phospholamban R14del disease: The past, the present and the future.
Vafiadaki E et al.
Frontiers in Cardiovascular Medicine, 2023
A study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations.
Truszkowska GT et al.
Bmc Medical Genetics, 2015
No evidence for an association between the -36A>C phospholamban gene polymorphism and a worse prognosis in heart failure.
Santos DG et al.
Bmc Cardiovascular Disorders, 2009
A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids.
Haghighi K et al.
Human Mutation, 2008
Mutational screening of phospholamban gene in hypertrophic and idiopathic dilated cardiomyopathy and functional study of the PLN -42 C>G mutation.
Medin M et al.
European Journal of Heart Failure, 2007
Select a paper to view details